Last updated on February 2018

Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years


Brief description of study

This study evaluates the effect of different induction courses in children and adolescents with newly diagnosed acute myeloid leukemia. In the first course patients are randomised to receive either standard anthracycline therapy with mitoxantrone or experimental DaunoXome. In the second course patients are randomised between standard treatment with ADxE (cytarabine, DaunoXome, etoposide) or experimental therapy with FLADx (fludarabine, cytarabine, DaunoXome).

Clinical Study Identifier: NCT01828489

Find a site near you

Start Over

CHC Esp rance

Montegnée, Belgium
  Connect »